Get the Stockscreener App
10.68
1.84%
-0.20
Mind Medicine Inc stock is traded at $10.68, with a volume of 1.73M.
It is down -1.84% in the last 24 hours and down -15.51% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$10.88
Open:
$10.87
24h Volume:
1.73M
Relative Volume:
0.96
Market Cap:
$1.05B
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-4.3592
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
-5.90%
1M Performance:
-15.51%
6M Performance:
+53.89%
1Y Performance:
+50.63%
1-Day Range:
$10.46
$11.11
1-Week Range:
$10.46
$11.82
52-Week Range:
$4.70
$14.43
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
10.68 | 1.06B | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Aug-04-25 | Resumed | Oppenheimer | Outperform |
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
Behavioral Patterns of MNMD and Institutional Flows - news.stocktradersdaily.com
Can Mind Medicine (MindMed) Inc. stock weather global recessionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
How Mind Medicine (MindMed) Inc. stock reacts to Fed rate cutsForecast Cut & Expert Curated Trade Ideas - newser.com
How Mind Medicine (MindMed) Inc. (MMQ) stock compares with tech leaders2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Is Mind Medicine (MindMed) Inc. (MMQ) stock undervalued after correctionWeekly Loss Report & Fast Moving Trade Plans - newser.com
How Mind Medicine (MindMed) Inc. stock performs in rising dollar environmentInsider Selling & Free Expert Verified Stock Movement Alerts - newser.com
Will Mind Medicine (MindMed) Inc. stock beat EPS estimatesJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
Will Mind Medicine (MindMed) Inc. rebound enough to break evenFed Meeting & Technical Pattern Alert System - newser.com
Risk vs reward if holding onto Mind Medicine (MindMed) Inc.July 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com
Can Mind Medicine (MindMed) Inc. stock outperform in 2025 bull marketStop Loss & Growth Focused Stock Pick Reports - newser.com
Anxious Times Ahead: MNMD's Pipeline Nears Its Make-or-Break Test In 2026 - RTTNews
Is Mind Medicine (MindMed) Inc. stock trading at a premium valuation2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
Will Mind Medicine (MindMed) Inc. stock deliver long term returnsQuarterly Profit Summary & Precise Buy Zone Identification - newser.com
Analyzing net buyer seller activity in Mind Medicine (MindMed) Inc.Market Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Mind Medicine’s Phase 3 Trial for Anxiety: A Potential Game-Changer? - MSN
Automated trading signals detected on Mind Medicine (MindMed) Inc.M&A Rumor & Technical Pattern Based Signals - newser.com
Predicting Mind Medicine (MindMed) Inc. trend using moving averagesTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com
Will Mind Medicine (MindMed) Inc. price bounce be sustainableTrade Exit Report & Weekly High Conviction Trade Ideas - newser.com
MindMed’s Earnings Call: Positive Outlook Amid Financial Challenges - MSN
Will Mind Medicine (MindMed) Inc. stock benefit from commodity pricesMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):